Stock listing

Hbm Holdings Ltd.

Selected listing: 2142 · HKEX · HKD · HK

Hbm Holdings Ltd. (HKEX:2142), Health Technology. Latest release May 8, 2026: Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment…

2142:HKEXHKDHKUpdated September 25, 2026

Ticker: HKEX:2142
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Other
Exchange: HKEX
Currency: HKD

About Hbm Holdings Ltd.

Hbm Holdings Ltd. is a publicly traded company on the Hong Kong Stock Exchange under the ticker 2142. Hbm Holdings focuses on its core business operations, contributing to its presence in the market.

Latest news from Hbm Holdings Ltd.

Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors

May 8, 2026

Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Atopic Dermatitis

March 9, 2026

Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results

February 2, 2026

Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration

January 17, 2026

Control Devices Acquires Sherwood Valve

January 12, 2026

All Hbm Holdings Ltd. news →

Research Hbm Holdings Ltd.

Hbm Holdings Ltd. company profile

View the public company page for Hbm Holdings Ltd. on 6ix.

Hbm Holdings Ltd. news

Read company news and market updates connected to Hbm Holdings Ltd..

Hbm Holdings Ltd. investor events

Find investor webinars, events, and replay context for Hbm Holdings Ltd..